Brainstorm Cell Stock Forecast - Price Action Indicator
| GHDN Stock | EUR 2.69 0.00 0.00% |
Brainstorm Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Brainstorm Cell's historical fundamentals, such as revenue growth or operating cash flow patterns.
Brainstorm |
| Check Brainstorm Cell Volatility | Backtest Brainstorm Cell | Information Ratio |
Brainstorm Cell Trading Date Momentum
| On December 15 2024 Brainstorm Cell Therapeutics was traded for 2.69 at the closing time. The maximum traded price for the trading interval was 2.69 and the lowest daily price was 2.69 . There was no trading activity during the period 0.0. Lack of trading volume on 15th of December 2024 did not affect price variability. The overall trading delta to the closing price today is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Brainstorm Cell to competition
Brainstorm Cell Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Brainstorm Cell Market Strength Events
Market strength indicators help investors to evaluate how Brainstorm Cell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brainstorm Cell shares will generate the highest return on investment. By undertsting and applying Brainstorm Cell stock market strength indicators, traders can identify Brainstorm Cell Therapeutics entry and exit signals to maximize returns.
Brainstorm Cell Risk Indicators
The analysis of Brainstorm Cell's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Brainstorm Cell's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting brainstorm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.75 | |||
| Standard Deviation | 3.32 | |||
| Variance | 11.0 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Brainstorm Stock
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.